GEMMATI, Donato
 Distribuzione geografica
Continente #
NA - Nord America 21.613
AS - Asia 13.504
EU - Europa 9.393
SA - Sud America 2.261
AF - Africa 319
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 18
Totale 47.140
Nazione #
US - Stati Uniti d'America 20.980
SG - Singapore 5.098
CN - Cina 3.334
IT - Italia 2.405
DE - Germania 1.871
BR - Brasile 1.784
VN - Vietnam 1.549
UA - Ucraina 1.248
HK - Hong Kong 1.163
GB - Regno Unito 851
PL - Polonia 786
TR - Turchia 697
FI - Finlandia 541
FR - Francia 451
JP - Giappone 387
CA - Canada 356
RU - Federazione Russa 334
IN - India 297
SE - Svezia 276
MX - Messico 208
AR - Argentina 176
ID - Indonesia 172
BD - Bangladesh 151
NL - Olanda 122
ZA - Sudafrica 117
IQ - Iraq 101
ES - Italia 79
BE - Belgio 70
PK - Pakistan 70
EC - Ecuador 67
CO - Colombia 66
VE - Venezuela 59
UZ - Uzbekistan 58
CZ - Repubblica Ceca 51
SA - Arabia Saudita 51
MA - Marocco 50
SM - San Marino 49
EG - Egitto 41
MY - Malesia 40
AT - Austria 39
PH - Filippine 38
CH - Svizzera 36
IR - Iran 36
AE - Emirati Arabi Uniti 35
LT - Lituania 35
CL - Cile 33
PY - Paraguay 33
IE - Irlanda 30
KE - Kenya 26
NP - Nepal 26
AU - Australia 25
TN - Tunisia 24
UY - Uruguay 21
RO - Romania 20
AZ - Azerbaigian 17
IL - Israele 17
JO - Giordania 17
TH - Thailandia 15
KZ - Kazakistan 14
GR - Grecia 13
LK - Sri Lanka 13
PT - Portogallo 13
TW - Taiwan 13
CR - Costa Rica 12
DZ - Algeria 12
LB - Libano 12
PE - Perù 12
PS - Palestinian Territory 12
SN - Senegal 12
DO - Repubblica Dominicana 11
KR - Corea 11
OM - Oman 11
AL - Albania 10
JM - Giamaica 10
BO - Bolivia 9
EU - Europa 9
DK - Danimarca 8
ET - Etiopia 8
SK - Slovacchia (Repubblica Slovacca) 8
BG - Bulgaria 7
BY - Bielorussia 7
GE - Georgia 7
KW - Kuwait 7
QA - Qatar 7
RS - Serbia 7
TT - Trinidad e Tobago 7
A2 - ???statistics.table.value.countryCode.A2??? 6
GT - Guatemala 6
HN - Honduras 6
HU - Ungheria 6
BH - Bahrain 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
NG - Nigeria 4
NI - Nicaragua 4
NO - Norvegia 4
PA - Panama 4
AO - Angola 3
CG - Congo 3
GD - Grenada 3
Totale 47.075
Città #
Singapore 3.011
Ashburn 2.196
Woodbridge 1.673
Fairfield 1.521
Jacksonville 1.360
Chandler 1.325
San Jose 1.290
Hong Kong 1.145
Beijing 1.040
Santa Clara 992
Houston 979
Ann Arbor 977
Warsaw 773
Seattle 619
Wilmington 614
Ho Chi Minh City 499
Cambridge 445
Izmir 422
Munich 411
Nanjing 390
Tokyo 365
New York 360
Hanoi 359
Los Angeles 352
Ferrara 325
Dallas 318
Princeton 291
Milan 277
Lauterbourg 273
Boardman 238
Helsinki 191
São Paulo 159
Council Bluffs 146
Mexico City 142
Shanghai 142
San Diego 141
Orem 138
Mcallen 130
Montréal 122
The Dalles 118
Shenyang 117
London 110
Rome 106
Bologna 101
Buffalo 101
Dearborn 98
Jakarta 98
Nanchang 96
Changsha 90
Tianjin 89
Da Nang 88
Turku 88
Hebei 86
Montreal 83
Bremen 81
Chennai 80
Chicago 77
Jiaxing 74
Toronto 73
Hefei 69
Denver 68
Frankfurt am Main 68
Haiphong 68
Rio de Janeiro 67
Brooklyn 64
Brussels 64
Johannesburg 61
Phoenix 55
Boston 53
Jinan 53
Redwood City 53
Düsseldorf 51
Greven 51
Belo Horizonte 50
Tashkent 50
Bottrop 49
Guangzhou 49
Norwalk 49
Stockholm 49
Falls Church 48
Baghdad 46
Berlin 45
Atlanta 43
Manchester 41
Moscow 41
Brasília 39
Nuremberg 39
San Francisco 39
Poplar 38
Dong Ket 37
Falkenstein 37
Mountain View 37
Amsterdam 36
Kunming 35
Zhengzhou 35
Naples 33
San Mateo 32
Des Moines 31
Mumbai 30
Ningbo 30
Totale 29.938
Nome #
Nanobiomaterials for vascular biology and wound management: a review 1.293
FISIOPATOLOGIA DELL'EMOSTASI E DELLA COAGULAZIONE 697
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 582
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 371
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 346
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 283
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 283
Fisiopatologia della Coagulazione. 280
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 277
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 276
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 266
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival 264
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 260
Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers 259
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 259
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes: new insights from a case-control study 256
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 256
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 253
Realizzazione di un DNA-Array di varianti genetiche nelle lesioni croniche di origine vascolare 251
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 246
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 245
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 244
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 244
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 243
High throughput array technologies: Expanding applications from clinics to applied research 242
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 241
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 239
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 237
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 235
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 235
FOLATE GENE VARIANTS AFFECT METHOTREXATE-RELATED TOXICITY IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS 235
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 234
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 233
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 231
Genetic predictors of response to photodynamic therapy 227
Prognostic role of Factor XIII gene variants in nonhealing venous leg ulcers 225
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 224
DNA-array of gene variants in venous leg ulcers: Detection of prognostic indicators 223
A deep vein thrombosis in an adolescent diabetic boy: A case report | [Descrizione di un caso di trombosi venosa profonda in un adolescente diabetico] 221
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 221
Influence of gene polymorphisms in ulcer healing process after superficial venous surgery 219
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 217
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 216
Fisiopatologia dell'Emostasi e della Coagulazione 216
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 216
A photometric assay for factor-XIII in chronic hepatopathies. 215
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 212
Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage 212
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 212
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis 210
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 208
Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration 207
Influence of Genetic Polymorphisms in Ulcer Healing Process after Superficial Venous Surgery 206
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 206
Quantitive evaluation of dentin sialoprotein (DSP) using microbeads - A potential early marker of root resorption 205
Investigation of in vitro cytotoxicity of the redox state of ionic iron in neuroblastoma cells. 204
Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants 203
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 203
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 203
MTHFR 677C→T polymorphism and risk of coronary heart disease: A meta-analysis 202
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review 200
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 199
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 199
Polymorphisms in the genes coding for iron binding and transporting proteins are Associated with Disability, Severity, and Early Progression in Multiple Sclerosis. 198
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 197
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 197
TIME- AND DOSE-DEPENDENT EFFECTS OF CHRONIC WOUND FLUID ON HUMAN ADULT DERMAL FIBROBLASTS 195
Nanoengineering Approaches to Design Advanced Dental Materials for Clinical Applications. 193
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 187
Partial gene deletion in a family with factor X deficiency 187
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes. 187
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 185
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 185
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients 184
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities 182
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 182
GENETIC SUSCEPTIBILITY IN VENOUS LEG ULCER 181
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 181
Meta-analysis of multiple sclerosis microarray data reveals dysregulation in RNA splicing regulatory genes 179
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 178
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 178
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 177
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 176
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 176
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 175
Folate: metabolism, biochemistry and role in disease processes. 174
Genetics and epigenetics of one-carbon metabolism pathway in autism spectrum disorder: A sex-specific brain epigenome? 174
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 173
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 172
A modified functional global test to measure PC, PS activities and the APC-resistance phenotype 172
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 171
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 171
The eclipse effect: the overlapping of varicose vein and C282Y heterozygous gene mutation 171
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 170
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 170
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 169
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 169
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 168
Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields 167
What is potentially the right factor XIII for venous leg ulcer treatment? 167
Totale 23.345
Categoria #
all - tutte 188.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.605
Totale 197.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.144 0 0 0 0 0 0 0 0 0 494 476 174
2021/20223.009 210 380 272 98 247 124 118 116 101 253 301 789
2022/20233.069 328 212 78 377 496 507 167 279 317 32 174 102
2023/20241.611 148 190 69 46 162 247 49 110 34 53 75 428
2024/20256.923 204 157 543 215 892 500 239 423 1.180 902 945 723
2025/202617.702 1.665 860 1.622 2.538 2.632 1.286 2.192 1.137 1.847 1.923 0 0
Totale 47.579